DXC Technology and Zafin Partner to Help Banks Manage Conduct Risk and Increase Customer Lifetime Value
Joint proposition enables Hogan core banking clients to enhance the sophistication and speed to market of today’s product and pricing strategies
LONDON, June 27, 2019 (GLOBE NEWSWIRE) -- DXC Technology, the world’s leading independent, end-to-end IT services company, and Zafin, a leading provider of product and pricing control solutions for financial institutions, have entered into a collaboration that will enable DXC’s core banking clients to make a strategic response to the changing demands of the marketplace.
A key aspect is the launch of a standardized data connector between DXC’s two core banking solutions, Hogan and Celeriti Digital Banking-as-a-Service, and Zafin’s cloud-based platform. This means that users can transform their product and pricing approach quickly, with low implementation costs and reduced operational risk. By externalizing product and pricing control from the core banking solutions, clients create an enhanced architecture that accelerates speed to market for new solutions, provides highly responsive relationship pricing, and bolsters controls and governance.
Since the global financial crisis, banking regulators’ oversight of banks has intensified, with a heightened focus on ensuring fair outcomes for clients. While banks have been responding to this increased scrutiny and the required investments in technology and process, the rise of asymmetric competitors, such as digital banks and other new entrants to financial services, has disrupted the hegemony of traditional banks with targeted solutions, aggressive pricing and a compelling client experience. Compounding these challenges, Open Banking continues to bring new business models and competition to the financial sector, while also creating significant compliance costs for the region’s banks.
“In today’s regulatory landscape, managing products and pricing effectively is a strategic imperative,” said Al Karim Somji, Founder and Group CEO at Zafin. “Banks need certainty as to the range of products and services to which their clients have access. At the same time, they must ensure that client pricing is fair, while substantiating to both clients and regulators that fees and interest are consistent with contractual obligations.”
“By working closely with DXC, we have responded to our clients’ demands for increased technical agility and interoperability between our solutions.”
“We’re always looking for ways to help our clients meet the ever-increasing expectations for personalized banking services,” said Phil Walton, Vice President and General Manager, DXC Celeriti. “Zafin enhances the relevance, precision and agility of their pricing strategies.”
“The Zafin platform is a complement to DXC’s core banking solutions, helping equip our clients for success in the modern era of financial services.”
Established in 2002, Zafin is a leading provider of product and pricing control solutions, enabling banks to manage conduct risk and increase customer lifetime value. In the current environment, it is critical for banks to have certainty around the products and services to which their clients have access, to ensure that pricing is appropriate and fair, and to substantiate that fees and interest are consistent with contractual arrangements. Zafin’s cloud-based SaaS platform can be implemented quickly, with minimal to no changes required to existing product systems. Headquartered in Toronto with offices around the globe, Zafin is trusted by some of the world’s largest retail and corporate banks. For more information about Zafin, visit zafin.com.
About DXC Technology
As the world's leading independent, end-to-end IT services company, DXC Technology (NYSE: DXC) leads digital transformations for clients by modernizing and integrating their mainstream IT, and by deploying digital solutions at scale to produce better business outcomes. The company’s technology independence, global talent, and extensive partner network enable 6,000 private and public-sector clients in 70 countries to thrive on change. DXC is a recognized leader in corporate responsibility. For more information, visit dxc.technology.
Uproar PR (Zafin)
(312) 878-4575 x240
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
PRF: Amendment to the financial calendar of AS PRFoods12.11.2019 19:00:00 CET | Press release
AS PRFoods has made the following amendment to the financial calender - Unaudited interim report for 3 months 2019/2020 will be published on the 30th of November 2019 instead of the 46th week as previously announced. Indrek Kasela AS PRFoods Member of the Management Board Phone: +372 452 1470 firstname.lastname@example.org www.prfoods.ee
Heijmans and De Wever: 220 homes in Berkel-Enschot and Tilburg12.11.2019 17:30:00 CET | Press release
Heijmans and geriatric care organization De Wever, which is an organisation that provides care to the elderly, have concluded a cooperation agreement for the phased development of approximately 220 owner-occupier and rental homes in Berkel-Enschot and Tilburg. Part of the homes (112 care apartments) is intended for senior citizens with divergent care needs. The project is valued at around € 65 million. Heijmans and De Wever respond to the increasing demand for suitable homes for senior citizens in Berkel-Enschot and Tilburg by means of this cooperation. Part of the apartments is intended for senior citizens who require nursing home care. With this project Heijmans contributes to creating a healthy living environment for these target groups. The project focuses among other things on laying out indoor and outdoor spaces intended for shared use, as a result of which residents can meet each other. A new apartment complex with 52 apartments for hospital (intramural) care is being realized i
Prosafe SE: Mandatory notification of trade12.11.2019 16:09:00 CET | Press release
Ryan Stewart, Chief Commercial Officer, has on 12 November 2019 purchased 45,000 shares in Prosafe SE at an average price of NOK 4.2565 per share. Following the transaction, Ryan Stewart owns 45,260 shares in Prosafe SE. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The Company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com Stavanger, 12 November 2019 Prosafe SE For further information, please contact: Jesper K. Andresen, CEO Phone: +47 51 65 24 30 / +47 907 65 155 Stig H. Christiansen, Deputy CEO and CFO Phone: +47 51 64 25 17 / +47 478 07 813 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
SDLP - Seadrill Partners LLC Third Quarter 2019 Cash Distribution12.11.2019 15:37:00 CET | Press release
London, United Kingdom, November 12, 2019 - Seadrill Partners LLC (OTCQB:SDLPF) ("Seadrill Partners" or the "Company") announces today that a distribution of $0.01 per unit has been declared with respect to the third quarter ended September 30, 2019, in line with the second quarter distribution. The third quarter cash distribution will be paid on November 27, 2019 to all unitholders of record as of the close of business on November 22, 2019. FORWARD LOOKING STATEMENTS This news release includes forward looking statements. Such statements are generally not historical in nature, and specifically include statements about the Company's plans, strategies, business prospects, changes and trends in its business and the markets in which it operates. In particular, statements regarding offshore drilling markets, the Company's ability to make cash distributions, the expected performance of the drilling units in the Company's fleet, estimated duration of customer contracts, contract dayrate amoun
DNO ASA: FAPE01 bond buyback12.11.2019 15:25:00 CET | Press release
Oslo, 12 November 2019 - DNO ASA, the Norwegian oil and gas operator, today purchased USD 2.6 million in nominal value of FAPE01 bonds (ISIN NO0010811268) originally issued by Faroe Petroleum plc, and renamed DNO North Sea plc. The bonds were purchased at a price of 107.25. Following the bond buyback, USD 23.6 million in nominal value of the FAPE01 bonds remain outstanding with DNO ASA holding the balance of USD 62.2 million. The FAPE01 bonds mature on 28 April 2023. -- For further information, please contact: Media: email@example.com Investors: firstname.lastname@example.org -- DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Netherlands, Ireland and Yemen. This information is subject to the disclosure requirements pursuant
PCI Biotech to present at BIO-Europe 201912.11.2019 15:11:00 CET | Press release
Oslo, Norway, November 12, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at BIO-Europe 2019 being held November 11-13, 2019 at Hamburg Messe, Germany. On Wednesday, November 13, 2019 at 09:15am (CET), Dr. Per Walday, CEO, will present an overview of PCI Biotech’s technology and the multiple business development and commercial opportunities available based on this proprietary platform. The presentation will be made available on PCI Biotech’s website (www.pcibiotech.com ) under “Other presentations”. About PCI Biotech PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. PCI is applied to three distinct anticancer paradigms: fimaChem (enhancement of chemotherapeutics for localised treatment of cancer), fi